Literature DB >> 19763659

Comparative study of clinical characteristics between Chinese Han and German Caucasian patients with coronary heart disease.

Yali Zheng1, Wenfei Ma, Yan Zeng, Jiani Liu, Shan Ye, Shaohua Chen, Ling Lan, Raimund Erbel, Qigong Liu.   

Abstract

BACKGROUND: The differences of the clinical characteristics, risk factors, treatment and prognosis in coronary heart disease (CHD) patients from different races, area and countries are rarely reported.
METHODS: Collecting, comparing and analyzing the clinical data and blood examination results of 650 Chinese Han and 640 German Caucasian patients with CHD.
RESULTS: The ratio of the first hospitalization because of CHD in Chinese patients was higher than that in Germans (95.1 vs. 38.1% P < 0.01). CHD occurred most frequently in elder men of both nations. The German CHD patients combined with hypertension, dyslipidemia and abnormal glucose metabolism were clearly more often than Chinese patients. Other risk factors such as fibrinogen, homocysteine and the proportion of positive family history of premature CHD, obesity, hyperuricemia were higher in German patients than that in Chinese patients. However, the ratio of smoking, acute myocardial infarction and the levels of high-sensitivity C-reactive protein in Chinese patients were obviously higher than that in Germans (P < 0.01, P < 0.05). The use of aspirin in both groups was the same, but the use of statins, beta-blockers and angiotensin-converting enzyme inhibitors/angiotensin-receptor blockers were distinctly lower in Chinese patients compared to Germans (P < 0.01, P < 0.05). The proportion of percutaneous coronary intervention and coronary artery bypass grafting in Chinese patients was lower than that in Germans (P < 0.01). The usage of drug-eluting stents to bare-metal stents was slightly higher in German patients, whereas it was obviously higher in Chinese patients (P < 0.01).
CONCLUSION: There were significant differences in clinical characteristics, risk factors and treatment of Chinese Han and German Caucasian patients with CHD.

Entities:  

Mesh:

Year:  2009        PMID: 19763659     DOI: 10.1007/s00392-009-0076-3

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  28 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

2.  Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes.

Authors:  Jean-Pierre Bassand; Christian W Hamm; Diego Ardissino; Eric Boersma; Andrzej Budaj; Francisco Fernández-Avilés; Keith A A Fox; David Hasdai; E Magnus Ohman; Lars Wallentin; William Wijns
Journal:  Eur Heart J       Date:  2007-06-14       Impact factor: 29.983

3.  Obesity: preventing and managing the global epidemic. Report of a WHO consultation.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  2000

4.  Prevalence of the metabolic syndrome and overweight among adults in China.

Authors:  Dongfeng Gu; Kristi Reynolds; Xigui Wu; Jing Chen; Xiufang Duan; Robert F Reynolds; Paul K Whelton; Jiang He
Journal:  Lancet       Date:  2005 Apr 16-22       Impact factor: 79.321

5.  Cardiovascular risk factors and mortality in patients with coronary heart disease.

Authors:  Christof Prugger; Jürgen Wellmann; Jan Heidrich; Stefan-Martin Brand-Herrmann; Ulrich Keil
Journal:  Eur J Epidemiol       Date:  2008-10-15       Impact factor: 8.082

6.  EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries.

Authors:  Kornelia Kotseva; David Wood; Guy De Backer; Dirk De Bacquer; Kalevi Pyörälä; Ulrich Keil
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2009-04

Review 7.  [Risk factors in atherosclerotic coronary heart disease].

Authors:  Danielle Hof; Arnold von Eckardstein
Journal:  Ther Umsch       Date:  2009-04

8.  China's health system performance.

Authors:  Yuanli Liu; Keqin Rao; Jing Wu; Emmanuela Gakidou
Journal:  Lancet       Date:  2008-10-17       Impact factor: 79.321

9.  Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.

Authors:  Jacques Bonnet; R McPherson; A Tedgui; D Simoneau; A Nozza; P Martineau; Jean Davignon
Journal:  Clin Ther       Date:  2008-12       Impact factor: 3.393

10.  Prevalence of cardiovascular disease and risk factors in a type 2 diabetic population of the North Catalonia diabetes study.

Authors:  Jeronimo Jurado; Juan Ybarra; Pascual Solanas; Jacint Caula; Ignasi Gich; Jose M Pou; June Hart Romeo
Journal:  J Am Acad Nurse Pract       Date:  2009-03
View more
  7 in total

1.  Impact of therapy with statins, beta-blockers and angiotensin-converting enzyme inhibitors on plasma myeloperoxidase in patients with coronary artery disease.

Authors:  Gjin Ndrepepa; Siegmund Braun; Albert Schömig; Adnan Kastrati
Journal:  Clin Res Cardiol       Date:  2010-11-05       Impact factor: 5.460

2.  Long-term prognosis in ethnic Chinese patients with unprotected left main coronary artery disease.

Authors:  Hui-Chun Huang; Hsien-Li Kao; Xue-Ming Wu; Sheoi-Shen Wang; Ron-Bin Hsu; Yi-Lwun Ho; Ming-Fong Chen
Journal:  Clin Res Cardiol       Date:  2010-03-14       Impact factor: 5.460

3.  Ethnic and sex differences in the incidence of hospitalized acute myocardial infarction: British Columbia, Canada 1995-2002.

Authors:  Aman P K Nijjar; Hong Wang; Hude Quan; Nadia A Khan
Journal:  BMC Cardiovasc Disord       Date:  2010-08-19       Impact factor: 2.298

4.  Inter-Ethnic Differences in Quantified Coronary Artery Disease Severity and All-Cause Mortality among Dutch and Singaporean Percutaneous Coronary Intervention Patients.

Authors:  Crystel M Gijsberts; Aruni Seneviratna; Imo E Hoefer; Pierfrancesco Agostoni; Saskia Z H Rittersma; Gerard Pasterkamp; Mikael Hartman; Leonardo Pinto de Carvalho; A Mark Richards; Folkert W Asselbergs; Dominique P V de Kleijn; Mark Y Chan
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

5.  Ethnicity Modifies Associations between Cardiovascular Risk Factors and Disease Severity in Parallel Dutch and Singapore Coronary Cohorts.

Authors:  Crystel M Gijsberts; Aruni Seneviratna; Leonardo P de Carvalho; Hester M den Ruijter; Puwalani Vidanapthirana; Vitaly Sorokin; Pieter Stella; Pierfrancesco Agostoni; Folkert W Asselbergs; A Mark Richards; Adrian F Low; Chi-Hang Lee; Huay Cheem Tan; Imo E Hoefer; Gerard Pasterkamp; Dominique P V de Kleijn; Mark Y Chan
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

6.  Genetic diversity and natural selection footprints of the glycine amidinotransferase gene in various human populations.

Authors:  Asifullah Khan; Lei Tian; Chao Zhang; Kai Yuan; Shuhua Xu
Journal:  Sci Rep       Date:  2016-01-05       Impact factor: 4.379

7.  Self-management of coronary heart disease in older patients after elective percutaneous transluminal coronary angioplasty.

Authors:  Susan Dawkes; Graeme D Smith; Lawrie Elliott; Robert Raeside; Jayne H Donaldson
Journal:  J Geriatr Cardiol       Date:  2016-07       Impact factor: 3.327

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.